Clinical study to evaluate the efficacy and safety of darbepoetin-alfa in kidney transplant recipients with erythropoietin-resistant anemia
Not Applicable
- Conditions
- Post-transplantation anemia
- Registration Number
- JPRN-UMIN000006661
- Lead Sponsor
- Osaka University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1.Patients with active infection or malignancy 2.Patients who receive surgical management
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1.Mean hemoglobin level at the end of the study. 2.Percentage of patients with hemoglobin level within the target range of 11 to 13 g/dL at the end of the study
- Secondary Outcome Measures
Name Time Method 1.Dose of darbepoetin-alfa 2.Changes in estimated glomerular filtration rate 3.Changes in blood pressure